Albumin Market 2022-2027: Size, Share, Trends, Analysis & Research Report

1. Global Albumin Market Research Report 2022-2027 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Albumin Market Outlook 2022-2027: The latest report by IMARC Group, titled “Albumin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global albumin market size reached US$ 5.4 Billion in 2021. Albumin refers to a water-soluble globular protein produced by the liver and found in blood plasma. It enters the bloodstream and prevents fluids from leaking out of the blood vessels into other tissues. It also maintains the blood volume, regulates intravascular colloid osmotic pressure (COP), and carries hormones, vitamins, and enzymes throughout the body. It is widely used as a blood volumizer to treat rare diseases, liver disorders, blood loss, shocks, surgical complications, and burns. Besides this, albumin finds extensive applications in manufacturing drug delivery systems, therapeutics, culture media, and vaccines. Request for a PDF sample of this report: https://www.imarcgroup.com/albumin- market/requestsample

4. Report Description and Highlights Report Description Global Albumin Market Drivers/Constraints: Albumin is extensively utilized for treating renal dialysis, liver failure, hypovolemia, acute respiratory distress syndrome, cardiopulmonary disorders, nephrosis, and hypoalbuminemia. As a result, the surging prevalence of chronic diseases represents the primary factor driving the market growth. Moreover, the expanding geriatric population that is more prone to developing such medical ailments is positively influencing the market growth. Furthermore, albumin is rapidly gaining traction as a pharmaceutical stabilizer to reduce the denaturation of protein-active ingredients. In line with this, the growing usage of human serum albumin (HSA) to replenish proteins in human plasma and regulate plasma colloid oncotic pressure has augmented the product demand. Apart from this, the rising adoption of HSA in pharmaceutical preparations, such as drug formulations and vaccines, is another major growth-inducing factor. In addition, the introduction of albumin-based nanoparticles and extensive investments in drug development and drug discovery activities in the biopharmaceutical industry have catalyzed market growth. View Report TOC, Figures and Tables: https://www.imarcgroup.com/albumin-market

5. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Product: • • • Human Serum Albumin Bovine Serum Albumin Recombinant Albumin Breakup by Application: • • • Therapeutics Drug Formulation and Vaccine Component of Media

6. Report Description and Highlights Report Description Breakup by End User: • • • Hospitals and Clinics Pharmaceutical and Biotechnology Companies Research Institutes Breakup by Region: • • • • • North America Asia Pacific Europe Latin America Middle East and Africa Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2027, exhibiting a CAGR of 6.15% during 2022-2027.

7. Report Description and Highlights Report Description Competitive Landscape: • • • • • • • • • • • • Albumedix Ltd Biotest AG Celgene Corporation (Bristol-Myers Squibb Company) CSL Limited Grifols SA HiMedia Laboratories Medxbio Pte Ltd Merck KGaA Octapharma AG Takeda Pharmaceutical Company Limited Thermo Fisher Scientific Inc Ventria Bioscience Inc Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click here: https://www.imarcgroup.com/albumin-market/requestsample

8. Key Questions Answered in the Report Report Description 1. What has been the historical growth rate of the global Albumin Market? 2. What has been the impact of COVID-19 on the global Albumin Market? 3. What are the key factors driving the global Albumin Market? 4. What is the breakup of the global Albumin Market based on the type? 5. What is the breakup of the global Albumin Market based on the application? 6. What is the breakup of the global Albumin Market based on the distribution channel? 7. What are the key regions in the global Albumin Market? 8. Who are the key players/companies in the global Albumin Market?

9. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends

10. Report DescriptionTable of Contents 5 Global Albumin Market Industry 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Breakup by Product 5.5 Market Breakup by Application 5.6 Market Breakup by End User 5.7 Market Breakup by Region Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/albumin-market/toc

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

13. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

14. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com